MICHAEL A DAVIES to Cyclin-Dependent Kinase Inhibitor p21
This is a "connection" page, showing publications MICHAEL A DAVIES has written about Cyclin-Dependent Kinase Inhibitor p21.
Connection Strength
0.355
-
Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma. J Immunother. 2012 Jan; 35(1):66-72.
Score: 0.355
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.